Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Eccentric exercise rehabilitation for patients after thoracic surgery

Official title: Respiratory Rehabilitation Based on Eccentric Exercice on Treadmill After Thoracic Surgery: a Randomized Clinical Trial

Run by Universidad Europea de Madrid · NCT06493877 · Data updated 2026-11-12

This study tests if a special exercise program on a treadmill can help people recover better after thoracic surgery by improving their breathing, strength, and overall quality of life.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment57 (estimated)
SponsorUniversidad Europea de Madrid
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Madrid)
StatusRecruiting
StartedSeptember 2024
Main results expectedSeptember 2025
Study endsSeptember 2027
Registry record updatedJuly 11, 2024
Trial IDNCT06493877 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 who have undergone thoracic surgery within the last 75 days and experience moderate dyspnea.

Probably not a fit

Patients with severe cardiac or pulmonary conditions that contraindicate physical training may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the effectiveness of a rehabilitation program that incorporates eccentric exercise on a treadmill for patients who have undergone thoracic surgery. The program aims to address issues such as dyspnea and improve lung capacity, muscle strength, and overall functionality. By combining respiratory physiotherapy with therapeutic exercise, the study seeks to enhance the quality of life for these patients and prevent long-term complications. The research will evaluate the short and medium-term benefits of this specific type of muscular work.

Why it matters

Potential benefit: If successful, this approach could significantly improve lung function and quality of life for patients recovering from thoracic surgery.

How similar studies have gone: Other studies have shown positive outcomes with similar rehabilitation approaches, indicating potential for success in this novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects \>18 years.
* Thoracic surgery in the previous 75 days
* Present dyspnea grade 2 - 3 on the mMRC scale.
* Cognitive and functional level sufficient to understand, learn and carry out the exercise program.
* Not have contraindications to perform physical training.
* Active collaborators.

Exclusion Criteria:

* Severe intolerance to exertion due to untreated cardiac arrhythmias, ischemia during low intensity exercise (anginas unstable), severe pulmonary hypertension, heart failure (NYHA III or IV)
* Pulmonary embolism with anticoagulant treatment less than 5 days.
* Recent cardiovascular events such as congestive heart failure, angioplasties or cardiac surgeries of less than four weeks' duration, valvular alterations requiring surgical correction, myopericarditis, ventricular arrhythmias caused by exercise.
* Kidney failure requiring dialysis.
* Patients with uncontrolled bronchospasm due to intrinsic asthma.
* Patients undergoing post-surgery chemotherapy treatment.
* Adverse effects that occurred during the development of the treatment.

Where it's running

  • Hospital Universitario Ramon y Cajal
    Madrid, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.